Pharmafile Logo
Pharmafocus logo
Advanced Search

Pfizer opens $200m R&D site in St Louis

pharmafile | April 21, 2009 | News story | Research and Development |  Pfizer, US 

Related Content

Coriolis Pharma opens new US headquarter and laboratory

Coriolis Pharma has opened a new US headquarter and laboratory at the Alexandria Center for …

Abselion establishes a US subsidiary in Massachusetts 

Abselion has established a US subsidiary at The Engine in Cambridge, Massachusetts in the US. …

ESTEVE CDMO commences $15.5m expansion of US facility

ESTEVE CDMO, a global Contract Development and Manufacturing Organization (CDMO) specialising in small molecule active pharmaceutical …

The Gateway to Local Adoption Series

Latest content

SMC accepts amivantamab and lazertinib for EGFR-positive lung cancer

May 22, 2026

BioDuro and CTI Biotechnology in preclinical drug development partnership

May 21, 2026

Sygnature Discovery appoints Susanne Back as Head of In Vivo Pharmacology

May 21, 2026

NICE recommends sotatercept for pulmonary arterial hypertension

May 20, 2026

Vetter begins construction of new injectable medicines facility

May 20, 2026